This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mizukami, Y. Articles by Chung, D. C. Search for Related Content PubMed PubMed Citation Articles by Mizukami, Y. Articles by Chung, D. C.

Hypoxia Inducible Factor-1–Independent Pathways in Tumor Angiogenesis

Authors' Affiliations: ¹ Division of Gastroenterology and Hematology/Oncology, Department of Medicine, Asahikawa Medical College, Asahikawa, Hokkaido, Japan and ² Gastrointestinal Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts

Requests for reprints: Yusuke Mizukami, Division of Gastroenterology and Hematology/Oncology, Department of Medicine, Asahikawa Medical College, 2-1 Midorigaoka-Higashi, Asahikawa, Hokkaido 078-8510, Japan. Phone: 81-166-68-2462; Fax: 81-166-68-2469; E-mail: mizu{at}asahikawa-med.ac.jp.

Abstract

Among the factors that can stimulate angiogenesis, vascular endothelial growth factor has emerged as one of the most important, and inhibition of vascular endothelial growth factor has recently shown efficacy in the treatment of advanced colorectal cancer. Hypoxia develops within solid tumors and is one of the most potent stimuli of vascular endothelial growth factor expression. This effect is mediated primarily by hypoxia inducible factor-1 (HIF-1), often considered a master regulator of angiogenesis in hypoxia. Consequently, inhibition of HIF-1 has been proposed as a strategy to block tumor angiogenesis therapeutically. However, accumulating evidence indicates that HIF-independent pathways can also control angiogenesis. This review highlights some of the key signaling pathways independent of HIF-1 that can stimulate angiogenesis in hypoxia. Understanding the full spectrum of molecular pathways that control tumor angiogenesis is critical for the optimal design of targeted therapies.

This article has been cited by other articles:

				J. M.G. Larkin, E. L.S. Kipps, C. J. Powell, and C. Swanton Review: Systemic therapy for advanced renal cell carcinoma Therapeutic Advances in Medical Oncology, July 1, 2009; 1(1): 15 - 27. [Abstract] [PDF]

				A. S. Chi, A. G. Sorensen, R. K. Jain, and T. T. Batchelor Angiogenesis as a Therapeutic Target in Malignant Gliomas Oncologist, June 1, 2009; 14(6): 621 - 636. [Abstract] [Full Text] [PDF]

				H. Schoder, M. Fury, N. Lee, and D. Kraus PET Monitoring of Therapy Response in Head and Neck Squamous Cell Carcinoma J. Nucl. Med., May 1, 2009; 50(Suppl_1): 74S - 88S. [Abstract] [Full Text] [PDF]

				K. Tsuchihara, Y. Suzuki, H. Wakaguri, T. Irie, K. Tanimoto, S.-i. Hashimoto, K. Matsushima, J. Mizushima-Sugano, R. Yamashita, K. Nakai, et al. Massive transcriptional start site analysis of human genes in hypoxia cells Nucleic Acids Res., April 1, 2009; 37(7): 2249 - 2263. [Abstract] [Full Text] [PDF]

				J. Lu, K. Zhang, S. Chen, and W. Wen Grape seed extract inhibits VEGF expression via reducing HIF-1{alpha} protein expression Carcinogenesis, April 1, 2009; 30(4): 636 - 644. [Abstract] [Full Text] [PDF]

				E. F. Moreira, I. M. Larrayoz, J. W. Lee, and I. R. Rodriguez 7-Ketocholesterol Is Present in Lipid Deposits in the Primate Retina: Potential Implication in the Induction of VEGF and CNV Formation Invest. Ophthalmol. Vis. Sci., February 1, 2009; 50(2): 523 - 532. [Abstract] [Full Text] [PDF]

				H. I. Hurwitz, J. Yi, W. Ince, W. F. Novotny, and O. Rosen The Clinical Benefit of Bevacizumab in Metastatic Colorectal Cancer Is Independent of K-ras Mutation Status: Analysis of a Phase III Study of Bevacizumab with Chemotherapy in Previously Untreated Metastatic Colorectal Cancer Oncologist, January 1, 2009; 14(1): 22 - 28. [Abstract] [Full Text] [PDF]

				K. J. Langen and S. M. Eschmann Correlative Imaging of Hypoxia and Angiogenesis in Oncology J. Nucl. Med., April 1, 2008; 49(4): 515 - 516. [Full Text] [PDF]

				M. Picchio, R. Beck, R. Haubner, S. Seidl, H.-J. Machulla, T. D. Johnson, H.-J. Wester, G. Reischl, M. Schwaiger, and M. Piert Intratumoral Spatial Distribution of Hypoxia and Angiogenesis Assessed by 18F-FAZA and 125I-Gluco-RGD Autoradiography J. Nucl. Med., April 1, 2008; 49(4): 597 - 605. [Abstract] [Full Text] [PDF]